Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• 25th DRUGMAKER TO IMPOSE 340B RESTRICTIONS ON HOSPITALS AND PHARMACY PARTNERS

  September 12, 2023 in 340B Health News Releases

• HOUSE DRUG SHORTAGE BILL WOULD PROVIDE WINDFALL TO DRUGMAKERS WHILE HARMING 340B HOSPITALS

  August 28, 2023 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  August 10, 2023 in 340B Health News Releases

• 340B HEALTH RESPONDS TO SENATE REQUEST FOR INFORMATION ON 340B

  July 31, 2023 in 340B Health News Releases

• HOSPITAL LEADER KAREN L. BOWLING ASSUMES CHAIR OF 340B HEALTH BOARD OF DIRECTORS

  July 14, 2023 in 340B Health News Releases

• DRUGMAKERS THREATENING $8.4 BILLION OF 340B HOSPITAL FUNDING THROUGH RESTRICTIONS

  July 11, 2023 in 340B Health News Releases

• STATEMENT ON CMS PROPOSED REMEDY FOR UNLAWFUL 340B MEDICARE PAYMENT CUTS

  July 07, 2023 in 340B Health News Releases

• ASTELLAS RESTRICTING 340B DISCOUNTS FOR COSTLY PROSTATE CANCER TREATMENT THROUGH COMMUNITY-BASED PHARMACIES

  July 03, 2023 in 340B Health News Releases

• STATEMENT ON SENATE REQUEST FOR INFORMATION ON SAFEGUARDING AND STRENGTHENING 340B

  June 16, 2023 in 340B Health News Releases

• STATEMENT ON TEVA RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  June 08, 2023 in 340B Health News Releases

• STATEMENT ON 22ND DRUG COMPANY REFUSING TO OFFER 340B DRUG PRICING; NOVO NORDISK FURTHER RESTRICTS 340B CONTRACT PHARMACY PRICING

  June 02, 2023 in 340B Health News Releases

• STATEMENT ON COMMITTEE PASSAGE OF HARMFUL HOUSE 340B LEGISLATION

  May 24, 2023 in 340B Health News Releases